Mitotic binding of Esrrb marks key regulatory regions of the pluripotency network

Nature Cell Biology

Volumn 18, Issue 11, 2016, Pages 1139-1148

  Festuccia, Nicola ^a   Dubois, Agnès ^a   Vandormael Pournin, Sandrine ^a   Gallego Tejeda, Elena ^a   Mouren, Adrien ^a   Bessonnard, Sylvain ^a   Mueller, Florian ^b   Proux, Caroline ^b   Cohen Tannoudji, Michel ^b   Navarro, Pablo ^a  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ESRRB; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; ESRRB PROTEIN, MOUSE; ESTROGEN RECEPTOR; PROTEIN BINDING;

ALLELE; ARTICLE; CELL SELF-RENEWAL; CHROMATIN; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; EMBRYO DEVELOPMENT; ESRRB GENE; GENE; GENE IDENTIFICATION; GENETIC ASSOCIATION; MITOSIS; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; C57BL MOUSE; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; MOUSE EMBRYONIC STEM CELL; PROCEDURES; REGULATORY SEQUENCE; TRANSGENIC MOUSE;

ANIMALS; CELL SELF RENEWAL; CELLULAR REPROGRAMMING; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOSIS; MOUSE EMBRYONIC STEM CELLS; PLURIPOTENT STEM CELLS; PROTEIN BINDING; RECEPTORS, ESTROGEN; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTIONAL ACTIVATION;

EID: 84990944472     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3418     Document Type: Article

References (60)

1. Smith, A. G. et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336, 688-690 (1988).
2. Kim, J., Chu, J., Shen, X., Wang, J. & Orkin, S. H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132, 1049-1061 (2008).
3. Chen, X. et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106-1117 (2008).
4. Chambers, I. et al. Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230-1234 (2007).
5. Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391 (1998).
6. Niwa, H., Miyazaki, J. & Smith, A. G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376 (2000).
7. Masui, S. et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9, 625-635 (2007).
8. Festuccia, N. et al. Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell 11, 477-490 (2012).
9. Martello, G. et al. Esrrb is a pivotal target of the gsk3/tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 11, 491-504 (2012).
10. Kopp, J. L., Ormsbee, B. D., Desler, M. & Rizzino, A. Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26, 903-911 (2008).
11. Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655 (2003).
12. Stead, E. et al. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 21, 8320-8333 (2002).
13. White, J. et al. Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Mol. Biol. Cell 16, 2018-2027 (2005).
14. Faast, R. et al. Cdk6-cyclin D3 activity in murine ES cells is resistant to inhibition by p16(INK4a). Oncogene 23, 491-502 (2004).
15. Dalton, S. Linking the cell cycle to cell fate decisions. Trends Cell Biol. 25, 592-600 (2015).
16. Martinez-Balbas, M. A., Dey, A., Rabindran, S. K., Ozato, K. & Wu, C. Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 83, 29-38 (1995).
17. Tsumura, A. et al. Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes Cells 11, 805-814 (2006).
18. Leeb, M. et al. Polycomb complexes act redundantly to repress genomic repeats and genes. Genes Dev. 24, 265-276 (2010).
19. Lehnertz, B. et al. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 13, 1192-1200 (2003).
20. Tachibana, M. et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16, 1779-1791 (2002).
21. De Los Angeles, A. et al. Hallmarks of pluripotency. Nature 525, 469-478 (2015).
22. Michelotti, E. F., Sanford, S. & Levens, D. Marking of active genes on mitotic chromosomes. Nature 388, 895-899 (1997).
23. Xing, H., Vanderford, N. L. & Sarge, K. D. The TBP-PP2A mitotic complex bookmarks genes by preventing condensin action. Nat. Cell Biol. 10, 1318-1323 (2008).
24. Zaidi, S. K. et al. Mitotic partitioning and selective reorganization of tissuespecific transcription factors in progeny cells. Proc. Natl Acad. Sci. USA 100, 14852-14857 (2003).
25. Blobel, G. A. et al. A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit. Mol. Cell 36, 970-983 (2009).
26. Young, D. W. et al. Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 445, 442-446 (2007).
27. Verdeguer, F. et al. A mitotic transcriptional switch in polycystic kidney disease. Nat. Med. 16, 106-110 (2009).
28. Caravaca, J. M. et al. Bookmarking by specific and nonspecific binding of FoxA1 pioneer factor to mitotic chromosomes. Genes Dev. 27, 251-260 (2013).
29. Kadauke, S. et al. Tissue-specific mitotic bookmarking by hematopoietic transcription factor GATA1. Cell 150, 725-737 (2012).
30. Guo, G. et al. Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst. Dev. Cell 18, 675-685 (2010).
31. Whyte, W. A. et al. Master transcription factors and mediator establish superenhancers at key cell identity genes. Cell 153, 307-319 (2013).
32. Shen, Y. et al. A map of the cis-regulatory sequences in the mouse genome. Nature 488, 116-120 (2012).
33. Brookes, E. et al. Polycomb associates genome-wide with a specific RNA polymerase II variant, and regulates metabolic genes in ESCs. Cell Stem Cell 10, 157-170 (2012).
34. Bulut-Karslioglu, A. Suv39h-dependent H3K9me3 marks intact retrotransposons and silences LINE elements in mouse embryonic stem cells. Mol. Cell 55, 277-290 (2014).
35. Farla, P. et al. The androgen receptor ligand-binding domain stabilizes DNA binding in living cells. J. Struct. Biol. 147, 50-61 (2004).
36. Sauer, M. et al. C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity. Nucleic Acids Res. 36, 1900-1912 (2008).
37. Mueller, F., Stasevich, T. J., Mazza, D. & McNally, J. G. Quantifying transcription factor kinetics: at work or at play? Crit. Rev. Biochem. Mol. Biol. 48, 492-514 (2013).
38. den Elzen, N. & Pines, J. Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase. J. Cell Biol. 153, 121-136 (2001).
39. Geley, S. et al. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J. Cell Biol. 153, 137-148 (2001).
40. Marks, H. et al. The transcriptional and epigenomic foundations of ground state pluripotency. Cell 149, 590-604 (2012).
41. Dixon, J. R. et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376-380 (2012).
42. Feng, B. et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat. Cell Biol. 11, 197-203 (2009).
43. Lerner, J. et al. Human mutations affect the epigenetic/bookmarking function of HNF1B. Nucleic Acids Res. http://dx. doi. org/10. 1093/nar/gkw467 (2016).
44. Soufi, A., Donahue, G. & Zaret, K. S. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 151, 994-1004 (2012).
45. Soufi, A. et al. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell 161, 555-568 (2015).
46. van den Berg, D. L. et al. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 6, 369-381 (2010).
47. Zaidi, S. K. et al. Mitotic bookmarking of genes: a novel dimension to epigenetic control. Nat. Rev. Genet. 11, 583-589 (2010).
48. Kadauke, S. & Blobel, G. A. Mitotic bookmarking by transcription factors. Epigenet. Chromatin 6, 6 (2013).
49. Zaret, K. S. Genome reactivation after the silence in mitosis: recapitulating mechanisms of development? Dev. Cell 29, 132-134 (2014).
50. Sela, Y., Molotski, N., Golan, S., Itskovitz-Eldor, J. & Soen, Y. Human embryonic stem cells exhibit increased propensity to differentiate during the G1 phase prior to phosphorylation of retinoblastoma protein. Stem Cells 30, 1097-1108 (2012).
51. Pauklin, S. & Vallier, L. The cell-cycle state of stem cells determines cell fate propensity. Cell 155, 135-147 (2013).
52. Boroviak, T., Loos, R., Bertone, P., Smith, A. & Nichols, J. The ability of innercell-mass cells to self-renew as embryonic stem cells is acquired following epiblast specification. Nat. Cell Biol. 16, 516-528 (2014).
53. Buganim, Y. et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150, 1209-1222 (2012).
54. Gearhart, M. D., Holmbeck, S. M., Evans, R. M., Dyson, H. J. & Wright, P. E. Monomeric complex of human orphan estrogen related receptor-2 with DNA: a pseudo-dimer interface mediates extended half-site recognition. J. Mol. Biol. 327, 819-832 (2003).
55. Mueller, F., Karpova, T. S., Mazza, D. & McNally, J. G. Monitoring dynamic binding of chromatin proteins in vivo by fluorescence recovery after photobleaching. Methods Mol. Biol. 833, 153-176 (2012).
56. van den Berg, D. L. et al. Estrogen-related receptor - interacts with Oct4 to positively regulate Nanog gene expression. Mol. Cell Biol. 28, 5986-5995 (2008).
57. Halbritter, F., Vaidya, H. J. & Tomlinson, S. R. GeneProf: analysis of high-throughput sequencing experiments. Nat. Methods 9, 7-8 (2012).
58. McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495-501 (2010).
59. Medina-Rivera, A. et al. RSAT 2015: regulatory sequence analysis tools. Nucleic Acids Res. 43, W50-W56 (2015).
60. Madsen, J. G. et al. iRNA-seq: computational method for genome-wide assessment of acute transcriptional regulation from total RNA-seq data. Nucleic Acids Res. 43, e40 (2015).